Cingulate Management
Management criteria checks 2/4
Cingulate's CEO is Shane Schaffer, appointed in Jan 2012, has a tenure of 12.83 years. total yearly compensation is $629.57K, comprised of 78.1% salary and 21.9% bonuses, including company stock and options. directly owns 0.005% of the company’s shares, worth $754.89. The average tenure of the management team and the board of directors is 6.8 years and 0.8 years respectively.
Key information
Shane Schaffer
Chief executive officer
US$629.6k
Total compensation
| CEO salary percentage | 78.1% |
| CEO tenure | 12.8yrs |
| CEO ownership | 0.005% |
| Management average tenure | 6.8yrs |
| Board average tenure | less than a year |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$16m |
| Jun 30 2024 | n/a | n/a | -US$19m |
| Mar 31 2024 | n/a | n/a | -US$23m |
| Dec 31 2023 | US$630k | US$492k | -US$24m |
| Sep 30 2023 | n/a | n/a | -US$21m |
| Jun 30 2023 | n/a | n/a | -US$19m |
| Mar 31 2023 | n/a | n/a | -US$17m |
| Dec 31 2022 | US$583k | US$475k | -US$18m |
| Sep 30 2022 | n/a | n/a | -US$16m |
| Jun 30 2022 | n/a | n/a | -US$27m |
| Mar 31 2022 | n/a | n/a | -US$24m |
| Dec 31 2021 | US$1m | US$475k | -US$21m |
| Sep 30 2021 | n/a | n/a | -US$19m |
| Jun 30 2021 | n/a | n/a | -US$5m |
| Mar 31 2021 | n/a | n/a | -US$6m |
| Dec 31 2020 | US$275k | US$275k | -US$7m |
Compensation vs Market: Shane's total compensation ($USD629.57K) is about average for companies of similar size in the US market ($USD646.00K).
Compensation vs Earnings: Shane's compensation has increased whilst the company is unprofitable.
CEO
Shane Schaffer (49 yo)
12.8yrs
Tenure
US$629,571
Compensation
Dr. Shane J. Schaffer, PharmD, co-founded Cingulate Inc. in 2012 and since serves as its Chief Executive Officer and Chairman of the Board and served as its Principal Financial Officer since December 13, 2...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 12.8yrs | US$629.57k | 0.0054% $ 754.9 | |
| Executive VP & COO | 6.6yrs | US$476.33k | 0% $ 0 | |
| Executive VP & Chief Medical Officer | 6.8yrs | US$267.73k | 0.084% $ 11.8k | |
| Senior VP | less than a year | no data | no data | |
| Executive VP & Chief Science Officer | 6.8yrs | no data | no data | |
| Vice President of Investor & Public Relations | no data | no data | no data |
6.8yrs
Average Tenure
60yo
Average Age
Experienced Management: CING's management team is seasoned and experienced (6.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 12.8yrs | US$629.57k | 0.0054% $ 754.9 | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Director | 6.4yrs | US$47.94k | 0.0029% $ 400.6 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
0.8yrs
Average Tenure
58yo
Average Age
Experienced Board: CING's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.